AAPS-FDA Workshop White Paper: microdialysis principles, application, and regulatory perspectives.
Chaurasia
Chandra S
CS
Division of Bioequivalence, Office of Generic Drugs, Food and Drug Administration, Room 1360/HFD-650, 7520 Standish Place, Rockville, MD 20855, USA. chandra.chaurasia@fda.hhs.gov
Müller
Markus
M
Bashaw
Edward D
ED
Benfeldt
Eva
E
Bolinder
Jan
J
Bullock
Ross
R
Bungay
Peter M
PM
DeLange
Elizabeth C M
EC
Derendorf
Hartmut
H
Elmquist
William F
WF
Hammarlund-Udenaes
Margareta
M
Joukhadar
Christian
C
Kellogg
Dean L
DL
Lunte
Craig E
CE
Nordstrom
Carl Henrik
CH
Rollema
Hans
H
Sawchuk
Ronald J
RJ
Cheung
Belinda W Y
BW
Shah
Vinod P
VP
Stahle
Lars
L
Ungerstedt
Urban
U
Welty
Devin F
DF
Yeo
Helen
H
D000818:Animals; D002138:Calibration; D004353:Drug Evaluation, Preclinical; D006801:Humans; D017551:Microdialysis / Q000009:adverse effects / Q000379:methods; D010599:Pharmacokinetics; D012957:Societies, Pharmaceutical; D014481:United States; D014486:United States Food and Drug Administration